GarciaMJMcNamaraPMGordonTKanneilWB: Morbidity and mortality in diabetics in the Framingham population: Sixteen year follow-up studyDiabetes1974, 23:105–111.
2.
FullerJHShipleyMJRoseGJarretRJKeenH: Coronary heart disease risk and impaired glucose tolerance: The Whitehall StudyLancet1980, i:1373–1376.
3.
BellDSH: Diabetic cardiomyopathy. A unique entity or a complication of coronary artery disease?Diabet Care1995, 18:708–714.
4.
UretskyBFFarquhanDBerezinAHoodW: Symptomatic myocardial infarction without chest pain: Prevalence and clinical courseAm J Cardiol1977, 40:498–503.
5.
AlmogCPikA: Acute myocardial infarction as a complication of diabetes mellitusJAMA1978, 239:2782.
6.
YuromRZirkinHStammlerGRoseAG: Human coronary microvessels in diabetes and ischemia: Morphometric study of autopsy materialJ Pathol1992, 166:265–270.
7.
KrolewskiASKosinskiEJWarramJHLelandOSBusickEJAsmalAC et al.: Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitusAm J Cardiol1987, 57:750–755.
8.
LernerDJKannelWB: Patterns of coronary artery disease morbidity and mortality in the sexes: A 26 year follow-up of the Framingham populationAm Heart J1986, 111:383–390.
9.
JensenTBorch-JohnsenKKofoed-EnevoldsenADeckertT: Coronary artery disease in young type I (insulin-dependent) diabetic patients with and without diabetic nephropathy: Incidence and risk factorsDiabetologia1985, 28:590–596.
10.
HermanJBMedalieJHGoldbourtV: Differences in cardiovascular morbidity and mortality between previously known and newly diagnosed adult diabeticsDiabetologia1977, 13:229–234.
11.
FullerJHShipleyMJRoseGJarrettRJKeenH: Mortality from coronary heart disease and stroke in relation to degree of glycemia: The Whitehall StudyBMJ1983, 287:867–870.
12.
EschwegeEDucimetièrePThilbultNRichardJLClaudeJRRosselinGE: Coronary heart disease in relation with diabetes, blood glucose, and plasma insulin levels. The Paris Prospective Study, ten years laterHorm Metab Res1985, 15:41–45.
13.
ReunanenALaaksoMPyoralaK: Cardiovascular and coronary heart disease mortality of diabetics and non-diabetics: Impact of risk factorsJ Am Coll Cardiol1983, 1:600.
14.
RosengrenANelinLTsipogianniAWilhelmsenL: Impact of cardiovascular risk factors on coronary heart disease and mortality among middle-aged men: A general population studyBMJ1989, 299:1127–1131.
15.
StamlerJVaccaroONeatonJDWentworthD: Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention TrialDiabetes Care1993, 16:434–444.
16.
UusitupaMSiitonenOAroAPyoralaK: Prevalence of coronary heart disease, left ventricular failure and hypertension in middle-aged newly diagnosed type 2 (non-insulin-dependent) diabetic subjectsDiabetologia1985, 28:22–27.
17.
PyoralaK: Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: Results from two population studies in FinlandDiabetes Care1979, 2:131–141.
18.
CrallFVRobertsWC: The extramural and intramural coronary arteries in juvenile diabetes mellitusAm J Med1978, 64:221–230.
19.
BellET: A post-mortem study of vascular disease in diabeticsArch Pathol1952, 53:444–455.
20.
RobersonWBStrongJP: Atherosclerosis in persons with hypertension and diabetesLab Invest1968, 18:538–551.
21.
WallerBPalumboPRobertsN: Status of the coronary arteries at necropsy in diabetes mellitus with onset after age 30 yearsAm J Med1980, 69:498–506.
22.
BaroldiGFulziGMarianaF.Sudden coronary death: A post-mortem study in 208 selected cases compared to 97 ‘control’ subjectsAm Heart J1978, 64:221–230.
23.
VigoritaVJMooreGWHutchinsGM: Absence of correlation between coronary arterial sclerosis and severity or duration of diabetes mellitus of adult onsetAm J Cardiol1980, 46:535–542.
24.
WeinrauchLAD'EliaJAHealeyRWGleasonREChristleibAR et al.: Asymptomatic coronary artery disease: Angiography in diabetic patients before renal transplantation. Relation of findings to postoperative survivalAnn Intern Med1978, 88:346–348.
25.
BennetWMKlosterFRoschJBarryJPorterGA: Natural history of asymptomatic coronary arteriographic lesions in diabetic patients with end-stage renal disease. Am J Med1978, 1615:779–784.
26.
BraunWEPhillipsDFVidtDTNovickACNakamotoSPopowniakKL et al.: Coronary disease in 100 patients with end-stage renal failureTransplant Proc1986, 16:603–607.
27.
WilsonCSGauGTFoultonREDavisGD: Coronary artery disease in diabetic and non-diabetic patients: A clinical and angiographic comparisonClin Cardiol1983, 6:440–446.
JarrettRJ: Risk factors for coronary heart disease in diabetes mellitusDiabetes1992, 41 (suppl 2):1–3.
30.
JensenTStenderSDeckertT: Abnormalities in plasma concentration of lipoproteins and fibrinogen in type 1 (insulin-dependent) diabetic patients with increased urinary albumin excretionDiabetologia1988, 31:142–145.
31.
JensenTBjerre-KnadsenJFeldt-RasmussenBDeckertT: Features of endothelial dysfunction in early diabetic nephropathyLancet1989, i:461–463.
32.
JonesSLCloseCFMatlockWMJarrettJKeenHVibertiGC: Plasma lipid and coagulation factor concentrations in insulin-dependent diabetic patients with microalbuminuriaBMJ1989, 298:487–490.
33.
ForsblomCMErikssonJGEkstrandAVTeppoAMTaskinenMRGroopLC: Insulin resistance and abnormal albumin excretion in non-diabetic first-degree relatives of patients with NIDDMDiabetologia1995, 38:363–369.
34.
MessentJWCElliotTGHillRDJarrettJKeenHVibertiG: Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus: A twenty three year follow-up studyKidney Int1992, 41:836–839.
35.
JarrettRJVibertiGCArgyropoulosAHillRDMahmudUMurrellsTJ: Microalbuminuria predicts mortality in non-insulin-dependent diabetesDiabet Med1984, 1:17–19.
36.
YudkinJSForrestRDJacksonCA: Microalbuminuria as a predictor of vascular disease in non-diabetic subjectsLancet1988, ii:530–533.
37.
YudkinJS: Coronary heart disease in diabetes mellitus: Three new risk factors and a unifying hypothesisJ Intern Med1995, 238: 21–30.
38.
BellDSH: Hypertension in the person with diabetesAm J Med Sci1989, 297:228–232.
39.
YudkinJS: Hypertension and coronary artery disease in non-insulin-dependent diabetes: Cause and effect?J Am Soc Nephrol1992, 3 (suppl):S126–S134.
40.
MacFarlaneIA.The smoker with diabetes: A difficult challengePostgrad Med J1991, 67: 928–930.
41.
HanefieldMSchulzeJFischerSJuliusUSchmechelHHullerH: The Diabetes Intervention Study: A cooperative multi-interventional trial with newly manifested type 2 diabetesMonogr Atheroscler1985, 13:98–103.
42.
HowardBV: Lipoprotein metabolism in diabetes mellitusJ Lipid Res1987, 28:613–625.
43.
WestKMAhujaMMSBennetPHCzyzykADe-AcostaOMFullerJH: The role of circulating glucose and triglyceride concentrations and their interaction with other risk factors as determinants of arterial disease in nine diabetic population samples. From the WHO Multinational StudyDiabet Care1983, 6:361–369.
44.
GarrisonRJNeatonJDCastelliWPKnokeJDJacobsDRBargdiwalaSTyrolerHA: High-density lipoprotein cholesterol and cardiovascular disease: Four prospective American studiesCirculation1989, 79:8–15.
45.
KraussRM: Low density lipoprotein subclasses and risk of coronary heart diseaseCurr Opin Lipidol1991, 2:248–252.
46.
HiramatsuKBiermanECChartA: Metabolism of low-density lipoprotein from patients with diabetic hypertriglyceridemia by cultured skin fibroblastsDiabetes1985, 34:8–14.
47.
Tilly-KiesiMSyvanneMKuusiTLahderpereS.TaskinenM-R: Abnormalities of low-density lipoproteins in normo-lipemic type 2 diabetic and non-diabetic patients with coronary heart diseaseJ Lipid Res1992, 33:333–342.
48.
Lopez-VirellaMFKleinRLLyonsTJStevensonHCWiztumJL: Glycosylation of low-density lipoprotein enhances cholesteryl esteral synthesis in human monocyte-derived macrophagesDiabetes1988, 37:550–557.
49.
SteinbergDParthasarthySCarewTEKhooJCWitztumJL: Beyond cholesterol. Modifications of low-density lipoprotein that increases its atherogenicityN Engl J Med1989, 320:915–924.
50.
HiramatsuKArimoriS: Increased superoxide production by mononuclear cells of patients with hypertriglyceridemia and diabetesDiabetes1988, 37:832–837.
51.
AvogaroPBitollo BonGCazzolatoGRorgiE: Relationship between apoproteins and chemical components of lipoproteins in survivors of myocardial infarctionAtherosclerosis1979, 37:69–76.
52.
HaffnerSMTuttleKRRainwaterDL: Lack of change of Lp(a) concentration with improved glycemic control in subjects with type II diabetesMetabolism1992, 41:116–120.
53.
ColwellJANairRMHaluskaPVRogersCWhetsellASagelJ: Platelet adhesion and aggregation in diabetes mellitusMetab Clin Exp1979, 28 (suppl 1):394–400.
54.
SagelJColwellJCrookLLaimansM: Increased platelet aggregation in early diabetes mellitusAnn Interm Med1975, 82:733–738.
55.
LufkinEGFassDNO'FallonWMBowieEJ: Increased von Willebrand* factor in diabetes mellitusMetabolism1979, 28:63–66.
56.
GersiniGFAbhateRFavillaSNeri-SerneriGC: Changes of platelet function and blood clotting in diabetes mellitusThromb Hemost1979, 42:983–993.
57.
Juhan-VagueIAlessiMCVagueP: Increased plasma plasminogen activator inhibitor 1 levels: A possible link between insulin resistance and atherothrombosisDiabetologia1991, 34:457–462.
58.
OlofssonBODahlerGNilssonTK: Evidence for increased levels of plasminogen activator inhibitor and tissue plasminogen activator in plasma of patients with angiographically verified coronary artery diseaseEur Heart J1989, 10:77–82.
59.
ReavenGM: Role of insulin resistance in human diseaseDiabetes1988, 37:1595–1607.
60.
GodslandIFStevensonJC: Insulin resistance: Syndrome or tendency?Lancet1995, 346:100–103.
61.
FontbonneA: Why can high insulin levels indicate a risk for coronary heart disease?Diabetologia1994, 37:953–955.
62.
JarretRJ: Why is insulin not a risk factor for coronary heart disease?Diabetologia1994, 37:945–947.
63.
JainSKNagiDKSlovinBMLumbPJYudkinIS: Insulin therapy in non-insulin dependent diabetic subjects suppresses concentrations of proinsulin-like molecules and plasminogen activator inhibitor independently from glycemic controlDiabet Med1993, 10:27–32.
64.
TempleRCCarringtonCALuzioSDOwensDRSchneiderAESobeyWJ et al.: Insulin deficiency in non-insulin dependent diabetesLancet1989, i:293–295.
65.
CeramiAVlassuraHBrownleeM: Role of advanced glycosylation products in complications of diabetesDiabet Care1988, 11 (suppl 1) 73–79.
66.
MakitaZRadoffSRayfieldEJYangZSkolnikEDelaneyV et al.: Advanced glycosylation end products in patients with diabetic nephropathyN Engl J Med1991, 325:836–842.
67.
KirsteinMBrettJRadoffSOwagaSSternDVlassuraH: Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: Role in vascular disease of diabetes and agingProc Natl Acad Sci USA1990, 87:9010–9014.
68.
BrownleeMVlassuraHKooneyAUlrichPCeramiA: Aminoguanidine prevents diabetes-induced arterial wall protein cross-linkingScience1986, 232:1629–1632.
69.
ColwellJANairRMHaluskaPVRogersCWhetsellASagelJ: Platelet adhesion and aggregation in diabetes mellitusMetab Clin Exp1979, 28:394–400.
70.
The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitusN Engl J Med1993, 329:977–986.
71.
ManskeCLWilsonRFWangYThomasW: Prevalence of and risk factors for angiographically determined coronary artery disease in Type 1 diabetic patients with nephropathyArch Intern Med1992, 152:2450–2455.
72.
KuusistoJMykkarenLPyorulaKLuaksoM: NIDDM and its metabolic control predict coronary heart disease in elderly subjectsDiabetes1994, 43:960–967.
73.
ArakiAYoshiyusuSHidekiI: Plasma homocysteine concentrations in Japanese patients with non-insulin dependent diabetes mellitus: Effect of parenteral methylcobalamin treatmentAtherosclerosis1993, 103:149–157.
74.
SieversJBlomquistGBioreLG: Studies on myocardial infarction in Malmo 1935 to 1954: Some clinical data with particular reference to diabetes, menopause, and heart ruptureActa Med Scand1961, 169:95–103.
75.
LyonsTJ: Oxidized low density lipoproteins: A role in the pathogenesis of atherosclerosis in diabetes?Diabet Med1991, 8:41–419.
76.
DaviesMThomasA: Plaque fissuring - the cause of acute myocardial infarction, sudden death and crescendo anginaBr Heart J1985, 53:363–373.
77.
PhilbinEFPearsonTA: How does lipid-lowering therapy rapidly reduce ischemic events?J Myocard Ischemia1994, 6:13–18.
78.
LynchMGammageMDLampPNuttrassMPentecostBL: Acute myocardial infarction in diabetic patients in the thrombolytic eraDiabet Med1994, 11:162–165.
79.
OpieCH: Metabolism of free fatty acids glucose and catecholamines in acute myocardial infarctionAm J Cardiol1975, 36:939–952.
80.
ClarkREnglishMMcNeilGNewtonR: Effect of intravenous infusion of insulin in diabetics with acute myocardial infarctionBMJ1985, 291:303–305.
81.
MalmbergKRydenLEfendicSHerlitzJNicolPWaldenstromA on behalf of the DIGAMI study group: Randomized trial on insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI): Effects on mortality at 1 yearJ Am Coll Cardiol1995, 26:57–65.
82.
GrossGJAuchampachJA: Role of ATP dependent potassium channels in myocardial ischemiaCardiovasc Res1992, 321:1231–1245.
83.
HermannLS Metformin: A review of its pharmacological properties and therapeutic useDiabet Metab1979, 5:233–245.
84.
KjekshusJGilpinECaliGBlackeyARHenningHRossJJr: Diabetic patients and beta blockers after acute myocardial InfarctionEur Heart J1990, 11:43–50.
85.
GrangerCBCaliffRMYoungSH: Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agentsJ Am Coll Cardiol1993, 2:920–925.
86.
ISIS-2 Collaborative Group: Randomized trial of intravenous streptokinase oral aspirin both or neither among 17 817 cases of suspected myocardial infarction: ISIS 2Lancet1988, ii:349–360.
87.
HollmanJBudhwarKBeckGJFrancoISimpfendorferC: Risk factors for recurrent stenosis following successful coronary angioplastyCleveland Clin J Med1989, 56:517–523.
88.
DeligonulUVandormaelMKernMGalanK: Repeat coronary angioplasty for restenosis: Results and predictors of follow-up clinical eventsAm Heart J1989, 117:697–1002.
89.
CurrozaJPJrKuntzREFishmanRFBaimPS: Restenosis after arterial injury caused by coronary stenting in patients with diabetes mellitusAnn Intern Med1993, 118:344–349.